Meghmani Organics Ltd

- No significant capital expenditure (capex) is planned for FY27; only routine capex of about INR 35-40 crores is expected. - The company has been actively working on improving working capital by rationalizing inventory levels and reducing receivable days. - There is no explicit mention of any new fundraising through debt or equity in the provided transcript content. - The company repaid approximately INR 160 crores of debt in FY26, with debt-to-equity ratios of 0.30x (standalone) and 0.47x (consolidated), indicating a focus on debt reduction. - Management did not indicate any plans for raising fresh equity or significant new debt during the FY27 period.

- No significant capex planned for FY27; only routine capex of approximately INR 35-40 crores is expected. - Manufacturing of new nano fertilizer products (Nano DAP, Nano NPK, Nano Zinc) will leverage existing infrastructure at Sanand facility with no additional capex. - Titanium Dioxide (TiO2) plant operations are temporarily suspended due to commercial unviability; no current capex on this project. - Focus on optimizing existing operations and improving working capital rather than major capital investments in the near term. - Scheme of amalgamation of wholly-owned subsidiaries to consolidate operations and achieve operational and financial synergies, not direct capex but strategic restructuring for resource optimization.

- Significant top-line growth expected over the next 3 to 5 years, driven mainly by the Crop Protection segment with double-digit growth. - Crop Nutrition segment to see reasonable growth supported by nano fertilizer products like Nano Urea, Nano DAP, Nano NPK, and Nano Zinc. - Continuous and growing demand for nano-based fertilizers due to fertilizer availability issues and government promotion. - Pigments segment expected to have flat to moderate revenue growth (INR 500-600 crores range) with improving profitability from cost optimization. - Overall, FY27 revenue and profitability expected to improve compared to FY26. - No specific quarter-wise projections, but steady growth anticipated across quarters depending on market seasons. - Long-term EBITDA margin guidance for Crop Protection maintained at 15%-17%.

- Management expects significant top-line and bottom-line growth over the next 3 to 5 years, driven primarily by the Crop Protection and Crop Nutrition segments. - Crop Protection segment is anticipated to achieve double-digit revenue growth with EBITDA margins in the range of 15% to 17% in FY27 and beyond. - Crop Nutrition segment (including nano-based fertilizers like Nano Urea, Nano DAP, Nano NPK) is expected to see substantial growth and improved profitability due to increasing farmer adoption amid fertilizer availability issues. - Pigments segment is projected to maintain stable revenues (INR 500-600 crores) with improved profitability through cost optimizations. - Overall profitability and EBITDA margins are expected to improve compared to previous challenging years, supported by price rationalization and operational efficiencies. - Management acknowledges recent difficult years but remains confident in long-term value creation and has plans to resume dividend payouts in FY27 reflecting better financial performance.

- Meghmani Organics currently has some orders for Nano Urea in the pipeline. - More orders are expected going forward, indicating a growing demand. - Orders will reflect in revenues on a quarter-on-quarter basis, varying by market and season. - Revenue growth from these orders is anticipated across all quarters within the financial year. - The management expects significant growth in both top line and bottom line from the Crop Nutrition segment, including Nano Urea and other nano-based fertilizers. - No specific quantification of pending orders or orderbook size was provided. - The outlook is positive, with continuous and increasing demand expected due to fertilizer availability issues and farmer adoption of nano-based fertilizers.